Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

PRP injections improve hair density in men with hair loss, with few short-term side effects.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

PRP injections significantly increased hair count and density with less pain.

Testosterone and finasteride improve muscle strength and size after spinal cord injury.

Intratesticular PRP injections are safe but not proven to improve sperm retrieval in certain infertile men.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

Estrogen alone can lower testosterone in some transfeminine people.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Injecting endometrial cells and PRP can improve pregnancy chances in ART.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Testosterone and finasteride improve body composition in men with spinal cord injury.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A treatment combining laser energy and injections improved hair loss and unexpectedly also reduced hair graying.